Sequenom, Inc. (NASDAQ: SQNM) announced new positive data from the prospective clinical studies using the Company's noninvasive SEQureDx(TM) technology, enabling ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE